Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
Diffusion weighted imaging-based tumor growth rate for predicting long-term survival in nasopharyngeal carcinoma.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Fan, Zhang Ya, Iv Michael, Wei Haoran, Wang Sai, Li Xiaolu, Yu Xiaoduo, Li Lin, Zhao Yanfeng, Xie Lizhi, Luo Dehong, Lin Meng, Zhang Hongmei
Аннотация
BACKGROUND: To explore the prognostic value of tumor special growth rate (TSGR) in patients with NPC and investigate the potential of diffusion-weighted imaging (DWI) habitat analysis as a surrogate marker.
METHODS: Patients who underwent two MRI scans before any type of treatment at two institutes were included. Radiologists manually delineated the volume of the primary tumor, and the doubling time and TSGR were calculated. Correlation between TSGR and long-term survival was evaluated using multivariate Cox analysis. Moreover, a radiologist delineated the tumor on b = 0 s/mm2 images during the first MRI scan. Each tumor was divided into two subregions based on the individual mean apparent diffusion coefficient value (ADCMean), and the ADC value (ADCdown [mm2/s] and ADCup [mm2/s]) of each subregion was calculated. ADC values for diagnosing TSGR and predicting survival were evaluated and validated using 5-fold cross-validation (iterations = 1000) and in an independent cohort.
RESULTS: A total of 98 patients were included (median age: 51 years; 24 females; training cohort: 64). The median doubling time was 131.9 days. Patients in the rapid-growth group (TSGR ≥ 1.4%) had significantly poorer survival than those in the slow-growth group (TSGR < 1.4%) in both the training and validation cohorts (p ≤ 0.006). ADCdown was a valuable factor in predicting TSGR (area under the curve: 0.792). Notably, the addition of ADCdown further improved the predictive value of TNM stage (0.663-0.848 vs. 0.631-0.785).
CONCLUSION: Patients with high ADCdown value may have the rapid-growth potential and were more likely to have a poor prognosis.
METHODS: Patients who underwent two MRI scans before any type of treatment at two institutes were included. Radiologists manually delineated the volume of the primary tumor, and the doubling time and TSGR were calculated. Correlation between TSGR and long-term survival was evaluated using multivariate Cox analysis. Moreover, a radiologist delineated the tumor on b = 0 s/mm2 images during the first MRI scan. Each tumor was divided into two subregions based on the individual mean apparent diffusion coefficient value (ADCMean), and the ADC value (ADCdown [mm2/s] and ADCup [mm2/s]) of each subregion was calculated. ADC values for diagnosing TSGR and predicting survival were evaluated and validated using 5-fold cross-validation (iterations = 1000) and in an independent cohort.
RESULTS: A total of 98 patients were included (median age: 51 years; 24 females; training cohort: 64). The median doubling time was 131.9 days. Patients in the rapid-growth group (TSGR ≥ 1.4%) had significantly poorer survival than those in the slow-growth group (TSGR < 1.4%) in both the training and validation cohorts (p ≤ 0.006). ADCdown was a valuable factor in predicting TSGR (area under the curve: 0.792). Notably, the addition of ADCdown further improved the predictive value of TNM stage (0.663-0.848 vs. 0.631-0.785).
CONCLUSION: Patients with high ADCdown value may have the rapid-growth potential and were more likely to have a poor prognosis.